Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor
NYU School of Global Public Health - Professor
Education
PhD, Social Psychology, University of Michigan, Ann ArborBA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis BIO
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention. Projects
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications
Recent
Des Jarlais DC, Weng CA, Feelemyer J, McKnight C (2023).
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Harm Reduction Journal, 20 (1), 63. doi: 10.1186/s12954-023-00791-0. PMCID: PMC10156073.
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Harm Reduction Journal, 20 (1), 63. doi: 10.1186/s12954-023-00791-0. PMCID: PMC10156073.
Des Jarlais DC, Lieff S, Grivel M, Meltzer G, Choi J, Weng CA, Feelemyer JP, Chang VW, Yang L (2023).
COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources
PLoS One, 18 (4), e0283467. doi: 10.1371/journal.pone.0283467. PMCID: PMC10138268.
COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources
PLoS One, 18 (4), e0283467. doi: 10.1371/journal.pone.0283467. PMCID: PMC10138268.
Wiessing L, Sypsa V, Abagiu AO, ... Feelemyer J, ...Hatzakis A..., Des Jarlais D (2023).
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior, 27 (4), 1140-1153. doi: 10.1007/s10461-022-03851-x. PMCID: PMC9651099.
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior, 27 (4), 1140-1153. doi: 10.1007/s10461-022-03851-x. PMCID: PMC9651099.
Ibitoye M, Bennett AS, Bugaghis M, Chernick LS, Des Jarlais DC, Aronson ID (2023).
Provider perspectives on barriers to routine HIV testing of adolescent and young adult patients in emergency department settings
Behavioral Medicine, 49 (2), 204-211. doi: 10.1080/08964289.2021.2020207. PMCID: PMC9240108.
Provider perspectives on barriers to routine HIV testing of adolescent and young adult patients in emergency department settings
Behavioral Medicine, 49 (2), 204-211. doi: 10.1080/08964289.2021.2020207. PMCID: PMC9240108.
Feelemyer J, Des Jarlais D, Nagot N, Huong DT, Oahn KTH, Khue PM, Giang HT, Thanh NTT, Cleland CM, Arasteh K, Caniglia E, Chen Y, Bart G, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Khan MR (2023).
Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
International Journal of STD and AIDS, 34 (4), 236-244. doi: 10.1177/09564624221142366.
Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
International Journal of STD and AIDS, 34 (4), 236-244. doi: 10.1177/09564624221142366.
Notable
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.
Dr. Des Jarlais' ResearchGate Profile
Selected Press